Differential NCKAP1 was also revealed via the GEPIA platform across different cancer stages, especially for bladder urothelial carcinoma (BLCA), KIRC, and several other specific cancer types, with noteworthy outcomes (Figure 1B). Here, NCKAP1 is linked to bladder transitional cell carcinoma.